Literature DB >> 22186355

Different outcomes for omega-3 heart trials: why?

Richard J Deckelbaum, Philip C Calder.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22186355     DOI: 10.1097/MCO.0b013e32834ec9e5

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


× No keyword cloud information.
  6 in total

1.  Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study.

Authors:  William S Harris; Juhua Luo; James V Pottala; Mark A Espeland; Karen L Margolis; Joann E Manson; Lu Wang; Theodore M Brasky; Jennifer G Robinson
Journal:  J Clin Lipidol       Date:  2017-01-12       Impact factor: 4.766

Review 2.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

3.  Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Authors:  Chuchun L Chang; Claudia Torrejon; Un Ju Jung; Kristin Graf; Richard J Deckelbaum
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

4.  Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: the TRIUMPH Study.

Authors:  William S Harris; K F Kennedy; T M Maddox; S Kutty; J A Spertus
Journal:  Nutr Res       Date:  2015-11-14       Impact factor: 3.315

5.  Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord.

Authors:  Hylde Zirpoli; Chuchun L Chang; Yvon A Carpentier; Adina T Michael-Titus; Vadim S Ten; Richard J Deckelbaum
Journal:  Annu Rev Nutr       Date:  2020-09-23       Impact factor: 11.848

6.  Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study.

Authors:  William S Harris; Nathan L Tintle; Mark R Etherton; Ramachandran S Vasan
Journal:  J Clin Lipidol       Date:  2018-03-02       Impact factor: 4.766

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.